Related Experiment Video
Updated: Jan 23, 2026

Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors
Published on: October 9, 2016
Small-Molecule CSF1R Inhibitors as Anticancer Agents.
Qiuju Xun1, Zhen Wang1, Xianglong Hu1
1International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Tumor-Associated Macrophages (TAMs) drive cancer growth and suppress immunity. Inhibiting CSF1R kinase, which controls TAMs, shows promise for new cancer treatments, with several small molecule inhibitors in clinical trials.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Tumor-Associated Macrophages (TAMs) infiltration is linked to cancer progression and immune suppression.
- Colony Stimulating Factor-1 Receptor (CSF1R) signaling is crucial for TAM behavior and its dysregulation contributes to cancer.
- CSF1R kinase is a significant target for developing novel anticancer therapies.
Purpose of the Study:
- To review the progress in developing small molecule CSF1R inhibitors for cancer treatment.
- To highlight compounds that have reached advanced clinical trial stages.
Main Methods:
- Literature review of scientific publications and clinical trial data.
- Focus on small molecule inhibitors targeting CSF1R kinase.
Main Results:
- Significant research efforts have yielded numerous small molecule CSF1R inhibitors.
- Several inhibitors are currently in advanced stages of clinical trials for various cancers.
Conclusions:
- Small molecule CSF1R inhibitors represent a promising therapeutic strategy for cancer.
- Further development and clinical evaluation are essential to realize their full potential in oncology.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Molecules and Compounds
Subviral Agents
Negative Regulator Molecules
Air-entraining Agents

